Presentation
May 16 2021
2020 Status Report: National implementation of the International Code of the Marketing of Breast-milk Substitutes
This presentation from WHO was made at the launch of the 2020 Status Report of the National Implementation of the International Code of the Marketing of Breast-milk Substitutes.
Brief
May 16 2021
Implementing the Breast-Milk Substitutes Act in Bangladesh: Guidance for employers, media and health administrators
These three briefs, published in 2021, explain the Bangladesh Breast-Milk Substitutes Act and what specific stakeholders - company owners, health administrators and the media - need to know about it.
Brief
May 16 2021
The Bangladesh Breastmilk Substitutes (BMS) Act
This policy brief summarizes the key provisions of the Bangladesh Breastmilk Substitutes, Infant Foods, Commercially Manufactured Complementary Foods, and the Accessories Thereof (Regulation of Marketing) Act (the Bangladesh BMS Act), which was adopted by Parliament in 2013 and sup
Brief
May 16 2021
Legislation to Protect Breastfeeding in Viet Nam: A Stronger Decree 21 Can Improve Child Nutrition and Reduce Stunting
Adopted in 2006, Decree 21 aimed to support optimal infant and young child feeding (IYCF) by limiting how and where breast milk substitutes can be promoted.
Brief
May 16 2021
Why National Policies Should Support Breastfeeding: The Benefits of Breast Milk vs. Infant Formula
Exclusive breastfeeding for the first six months of life is the single most effective intervention for preventing child deaths.
Presentation
May 16 2021
Inappropriate promotion of Japanese formula products in Southeast Asia countries
This slidedeck highlights the findings of a survey of violations of the BMS Code by Japanese companies across Southeast Asia. The survey was conducted by the Southeast Asia office of Alive & Thrive in 2018.